PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
1.195
+0.115 (10.65%)
Jun 1, 2026, 1:50 PM EDT - Market open
PDS Biotechnology Market Cap
PDS Biotechnology has a market cap or net worth of $66.7 million as of June 1, 2026. Its market cap has increased by 11.39% in one year.
Market Cap
66.70M
Enterprise Value
50.49M
1-Year Change
11.39%
Ranking
Category
Stock Price
$1.20
Market Cap Chart
Since March 18, 2019, PDS Biotechnology's market cap has increased from $45.51M to $66.70M, an increase of 46.55%. That is a compound annual growth rate of 5.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 60.28M | 43.10% |
| Dec 31, 2025 | 42.12M | -30.92% |
| Dec 31, 2024 | 60.98M | -60.56% |
| Dec 29, 2023 | 154.61M | -58.92% |
| Dec 30, 2022 | 376.31M | 63.37% |
| Dec 31, 2021 | 230.35M | 383.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entera Bio | 66.45M |
| ImageneBio | 66.32M |
| Edesa Biotech | 64.15M |
| PMV Pharmaceuticals | 64.00M |
| MiNK Therapeutics | 60.78M |
| Dogwood Therapeutics | 56.45M |
| Immutep | 56.18M |
| Impact BioMedical | 56.07M |